3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
118
Lung Neoplasms
9
Neoplasms
8
Triple Negative Breast Neoplasms
7
Ovarian Neoplasms
7
Neoplastic Cells, Circulating
6
Neoplasm Metastasis
5
Prostatic Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Hodgkin Disease
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Obesity
2
Melanoma
2
Lymphoma
2
Liver Neoplasms
2
Leukemia
2
Genetic Diseases, Inborn
2
Fibrosis
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Breast Diseases
2
Vulvar Neoplasms
1
Interventions
tucatinib
1
temsirolimus
1
pembrolizumab
1
niraparib
1
lenvatinib
1
atezolizumab
1
Valproic Acid
1
Trastuzumab
1
Tissue Banks
1
Sirolimus
1
Immunoglobulin G
1
Fulvestrant
1
Doxycycline
1
Disulfides
1
Cetuximab
1
Capecitabine
1
Blood Specimen Collection
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Blood Specimen Collection
×
Breast
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled